Market News

Latest financial and economic news and analysis

GlobeNewsWire News Agency
21 hours ago•GlobeNewsWire
Stocks Medium Importance Neutral
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Datavault AI Inc. (DVLT)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Datavault AI Inc. (DVLT)

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT) securities between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”).

Related Symbols 1
DVLT DVLT
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment
Reuters News Agency
21 hours ago•Reuters
Stocks Medium Importance Neutral
Iraq's KRG says Dana Gas, Crescent Petroleum breached contract over Khor Mor gas supplies

Iraq's KRG says Dana Gas, Crescent Petroleum breached contract over Khor Mor gas supplies

Iraq's Kurdistan Regional ​Government (KRG) said on Thursday that Dana Gas and Crescent Petroleum had breached their contractual obligations ‌by starting natural gas supplies from the Khor Mor field to Iraq's electricity ministry without its approval.

Related Symbols 1
KRG KRG
Source: Reuters
Visit Source
0 0 0
Read More
Comment
Proactive Investors News Agency
21 hours ago•Proactive Investors
Stocks Medium Importance Neutral
Apple App Store revenue ticks up despite falling downloads

Apple App Store revenue ticks up despite falling downloads

Apple Inc (NASDAQ:AAPL, XETRA:APC) App Store revenue rose 0.6% year-over-year in the first 35 days of its fiscal fourth quarter to $3.4 billion, up from $3.38 billion in the same period last year, according to a note from Bank of America. Total downloads across iPhone and iPad fell 4% year-over-year to 3.3 billion over the same stretch, while App Store dollars per download climbed 4.7% to $1.02, BofA said, citing data from SensorTower.

Related Symbols 1
AAPL Apple Inc.
Source: Proactive Investors
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
21 hours ago•GlobeNewsWire
Stocks Medium Importance Neutral
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired ARS Pharmaceuticals Inc. (ARS Pharm. or the “Company”) (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”).

Related Symbols 1
SPRY SPRY
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment
Newsfile Corp News Agency
21 hours ago•Newsfile Corp
Stocks Medium Importance Neutral
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026

Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. ("ARS" or the "Company") (NASDAQ: SPRY) on behalf of investors that purchased or otherwise acquired ARS securities between March 9, 2026 and June 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in ARS and have suffered losses, you may CLICK HERE to contact us.

Related Symbols 1
SPRY SPRY
Source: Newsfile Corp
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
22 hours ago•Zacks Investment Research
Stocks Medium Importance Neutral
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.

Related Symbols 1
ANGO ANGO
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
PYMNTS News Agency
22 hours ago•PYMNTS
Stocks Medium Importance Neutral
Buyer-Funded Revenue Powers Priority Technology Holdings' Payables Surge

Buyer-Funded Revenue Powers Priority Technology Holdings' Payables Surge

Priority Technology Holdings' Payables segment led the company's revenue growth in the second quarter, thanks to an increase in buyer-funded revenues, according to a presentation released Thursday (Aug. 6) in conjunction with an earnings call. Overall, Priority Technology Holdings' connected commerce engine saw its second-quarter revenue increase 9% year over year to $262.

Related Symbols 1
PRTH PRTH
Source: PYMNTS
Visit Source
0 0 0
Read More
Comment
PRNewsWire News Agency
22 hours ago•PRNewsWire
Stocks Medium Importance Neutral
FirstEnergy Foundation Supports New Jersey Disaster Preparedness & Recovery with $100,000 Donation to the American Red Cross

FirstEnergy Foundation Supports New Jersey Disaster Preparedness & Recovery with $100,000 Donation to the American Red Cross

HOLMDEL, N.J., Aug. 6, 2026 /PRNewswire/ -- Following Jersey Central Power & Light's (JCP&L) comprehensive effort to restore power to customers impacted by four consecutive days of devastating storms, today the FirstEnergy Foundation announced a $100,000 grant to the American Red Cross of New Jersey.

Related Symbols 1
FE FE
Source: PRNewsWire
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
22 hours ago•Seeking Alpha
Stocks Medium Importance Neutral
Knife River: Low ROIC And Low Margins

Knife River: Low ROIC And Low Margins

Knife River Corporation remains rated Hold due to low ROIC, negative ROIC-WACC spread, and limited multiple expansion potential. Q2 results showed strong 13% revenue growth but margin compression from cost inflation and higher fuel prices, partially offset by 8% price increases. KNF's aggregates segment benefits from local monopolies, but overall industry capital returns remain structurally low versus peers like VMC and MLM.

Related Symbols 1
ROIC ROIC
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
22 hours ago•Zacks Investment Research
Stocks Medium Importance Neutral
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.

Related Symbols 1
ANGO ANGO
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment